The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling …

M Bakhtiyari, M Liaghat, F Aziziyan… - Cell Communication and …, 2023 - Springer
Acute myeloid leukemia (AML) comprises a multifarious and heterogeneous array of
illnesses characterized by the anomalous proliferation of myeloid cells in the bone marrow …

[HTML][HTML] Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions

B Wang, Y Ma, Y Zhang, X Yin - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Apoptosis signal-regulated kinase 1 (ASK1) is a member of the mitogen-activated protein
kinase kinase (MAP3K) family, whose activation and regulation are intricately associated …

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma

Y Liu, K Shao, W Yang, Q Shen, M Lu, Z Shao… - Cell Death & …, 2024 - nature.com
Hepatocellular carcinoma (HCC) is a highly heterogeneous and malignant cancer with poor
overall survival. The application of sorafenib is a major breakthrough in the treatment of …

The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway

H Zhang, Y Wang, C Liu, W Li, F Zhou, X Wang… - … -Research and Practice, 2022 - Elsevier
Abstract Apolipoprotein C1 (APOC1) is a member of the apolipoprotein family. In recent
years, more and more studies have shown that APOC1 participates in the occurrence and …

Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G2/M phase transition …

T Xue, Y Chen, J Xu, W Du… - … journal of oncology, 2023 - spandidos-publications.com
Lung cancer is the leading cause of cancer-related mortality worldwide. Non-small cell lung
cancer (NSCLC) is the most common pathological subtype of lung cancer and is associated …

Update on JNK inhibitor patents: 2015 to present

G Feng, X Yang, W Shuai, G Wang… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction c-Jun N-terminal kinase (JNK) regulates various biological processes through
the phosphorylation cascade and is closely associated with numerous diseases, including …

Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors

IA Schepetkin, OS Karpenko, AR Kovrizhina… - Molecules, 2023 - mdpi.com
The c-Jun N-terminal kinase (JNK) family includes three proteins (JNK1-3) that regulate
many physiological processes, including cell proliferation and differentiation, cell survival …

JNK signaling and its impact on neural cell maturation and differentiation

RD Castro-Torres, J Olloquequi, A Parcerisas, J Ureña… - Life Sciences, 2024 - Elsevier
Abstract C-Jun-N-terminal-kinases (JNKs), members of the mitogen-activated-protein-kinase
family, are significantly linked with neurological and neurodegenerative pathologies and …

Recent advances and future perspectives of noncompetitive proteasome inhibitors

G Zeng, Q Yu, R Zhuang, H Zhu, J Shao, J **… - Bioorganic …, 2023 - Elsevier
The proteasome regulates intracellular processes, maintains biological homeostasis, and
has shown great significance in the study of various diseases, such as neurodegenerative …

The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects

W Yuan, Y Shi, S Dai, M Deng, K Zhu, Y Xu… - Journal of Translational …, 2024 - Springer
Gastric cancer remains a significant health burden globally, especially prevalent in Asian
and European regions. Despite a notable decline in incidence in the United States and …